Literature DB >> 23133809

In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting.

Håkan Hall1, Irina Velikyan, Elisabeth Blom, Johan Ulin, Azita Monazzam, Lars Påhlman, Patrick Micke, Alkwin Wanders, William McBride, David M Goldenberg, Bengt Långström.   

Abstract

The carcinoembryonic antigen (CEA) was visualized in vitro in tissue from patients with colorectal cancer with trivalent bispecific antibody TF2 and two hapten molecules, [(67/68)Ga]Ga-IMP461 and [(67/68)Ga]Ga-IMP485 by means of pretargeting. Colorectal cancer tissue samples obtained from surgery at Uppsala University Hospital, were frozen fresh and cryosectioned. The two hapten molecules comprising 1,4,7-triazacyclononanetriacetic acid chelate moiety (NOTA) were labeled with (67)Ga or (68)Ga. The autoradiography was conducted by incubating the tissue samples with the bispecific antibody TF2, followed by washing and incubation with one of the radiolabeled hapten molecules. After washing, drying and exposure to phosphor imager plates, the autoradiograms were analyzed and compared to standard histochemistry (hematoxylin-eosin). Pronounced binding was found in the tissue from colorectal cancer using the bispecific antibody TF2 and either of the haptens [(67/68)Ga]Ga-IMP461 and [(67/68)Ga]Ga-IMP485. Distinct binding was also detected in the epithelium of most samples of neighboring tissue, taken at a minimum of 10 cm from the site of the tumor. It is concluded that pretargeting CEA with the bispecific antibody TF2 followed by the addition of (67/68)Ga-labeled hapten is extremely sensitive for visualizing this marker for colorectal cancer. This methodology is therefore a very specific complement to other histochemical techniques in the diagnosis of biopsies or in samples taken from surgery. Use of the pretargeting technique in vivo may also be an advance in diagnosing patients with colorectal cancer, either using (67)Ga and SPECT or (68)Ga and PET.

Entities:  

Keywords:  Autoradiography; CEA; Ga-67; Ga-68; carcinoembryonic antigen; colorectal cancer; pretargeting

Year:  2012        PMID: 23133809      PMCID: PMC3477725     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  38 in total

1.  Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice.

Authors:  Rafke Schoffelen; Winette T A van der Graaf; Gerben Franssen; Robert M Sharkey; David M Goldenberg; William J McBride; Edmund A Rossi; Annemarie Eek; Wim J G Oyen; Otto C Boerman
Journal:  J Nucl Med       Date:  2010-11       Impact factor: 10.057

2.  Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.

Authors:  S Kodama; H Itoh; H Ide; H Kataoka; T Takehara; M Nagano; R Hamasuna; M Koono; Y Osada
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

Review 3.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Authors:  S Hammarström
Journal:  Semin Cancer Biol       Date:  1999-04       Impact factor: 15.707

4.  Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?

Authors:  L A Carriquiry; A Piñeyro
Journal:  Dis Colon Rectum       Date:  1999-07       Impact factor: 4.585

5.  A novel method of 18F radiolabeling for PET.

Authors:  William J McBride; Robert M Sharkey; Habibe Karacay; Christopher A D'Souza; Edmund A Rossi; Peter Laverman; Chien-Hsing Chang; Otto C Boerman; David M Goldenberg
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

6.  Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody.

Authors:  C Curtet; J P Vuillez; G Daniel; G Aillet; A Chetanneau; J Visset; M Kremer; P Thédrez; J F Chatal
Journal:  Eur J Nucl Med       Date:  1990

7.  Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis.

Authors:  Huan-Zhong Shi; Qiu-Li Liang; Jing Jiang; Xue-Jun Qin; Hai-Bo Yang
Journal:  Respirology       Date:  2008-04-14       Impact factor: 6.424

8.  Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.

Authors:  Robert M Sharkey; Habibe Karacay; Shankar Vallabhajosula; William J McBride; Edmund A Rossi; Chien-Hsing Chang; Stanley J Goldsmith; David M Goldenberg
Journal:  Radiology       Date:  2008-02       Impact factor: 11.105

Review 9.  Carcinoembryonic antigen in staging and follow-up of patients with solid tumors.

Authors:  A M Ballesta; R Molina; X Filella; J Jo; N Giménez
Journal:  Tumour Biol       Date:  1995

10.  Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.

Authors:  Hao Hong; Jiangtao Sun; Weibo Cai
Journal:  Biomark Insights       Date:  2008-09-23
View more
  9 in total

Review 1.  Functionalized upconversion nanoparticles: versatile nanoplatforms for translational research.

Authors:  F Chen; W Bu; W Cai; J Shi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 2.  ImmunoPET: Antibody-Based PET Imaging in Solid Tumors.

Authors:  Reyhaneh Manafi-Farid; Bahar Ataeinia; Shaghayegh Ranjbar; Zahra Jamshidi Araghi; Mohammad Mobin Moradi; Christian Pirich; Mohsen Beheshti
Journal:  Front Med (Lausanne)       Date:  2022-06-28

3.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

Review 4.  Prospective of ⁶⁸Ga-radiopharmaceutical development.

Authors:  Irina Velikyan
Journal:  Theranostics       Date:  2013-12-10       Impact factor: 11.556

5.  Evaluation of 68Ga-labeled MG7 antibody: a targeted probe for PET/CT imaging of gastric cancer.

Authors:  Bing Xu; Xiaowei Li; Jipeng Yin; Cong Liang; Lijuan Liu; Zhaoyan Qiu; Liping Yao; Yongzhan Nie; Jing Wang; Kaichun Wu
Journal:  Sci Rep       Date:  2015-03-03       Impact factor: 4.379

Review 6.  Recent advances of bispecific antibodies in solid tumors.

Authors:  Shengnan Yu; Anping Li; Qian Liu; Xun Yuan; Hanxiao Xu; Dechao Jiao; Richard G Pestell; Xinwei Han; Kongming Wu
Journal:  J Hematol Oncol       Date:  2017-09-20       Impact factor: 17.388

7.  Biodistribution and Tumor Uptake of 67Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft.

Authors:  Vanessa Izquierdo-Sánchez; Saé Muñiz-Hernández; Héctor Vázquez-Becerra; Judith Pacheco-Yepez; Mario E Romero-Piña; Oscar Arrieta; Luis Alberto Medina
Journal:  Molecules       Date:  2018-11-29       Impact factor: 4.411

8.  Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy.

Authors:  Samantha M Sarrett; Outi Keinänen; Eric J Dayts; Guillaume Dewaele-Le Roi; Cindy Rodriguez; Kathryn E Carnazza; Brian M Zeglis
Journal:  Nat Protoc       Date:  2021-06-14       Impact factor: 13.491

9.  Autoradiography screening of potential positron emission tomography tracers for asymptomatic abdominal aortic aneurysms.

Authors:  Gustaf Tegler; Sergio Estrada; Håkan Hall; Anders Wanhainen; Martin Björck; Jens Sörensen; Gunnar Antoni
Journal:  Ups J Med Sci       Date:  2014-02-21       Impact factor: 2.384

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.